Meghana Keshavan covers biotech and contributes to The Readout newsletter. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Biotech investors are far more selective than they were during the pandemic-era boom, JPMorgan's top EMEA healthcare investment bankers told CNBC. Many biotech companies are now pursuing a dual-track ...

In its annual Biotech Beyond Borders report, EY projects growth to continue throughout 2026, fueled primarily by the increased volume and value of M&A and licensing deals. (Techa Tungateja/GettyImages ...

Parabilis Medicines CEO Mathai Mammen, M.D., Ph.D., told Fierce the industry had been in “retreat mode for some time” before its latest rebound. (mesh cube/iStock/Getty Images Plus) Elon Musk's SpaceX ...

Jason Kelly is cofounder and CEO of Ginkgo Bioworks. He previously served as chair of the US National Security Commission on Emerging Biotechnology. Massachusetts helped invent the modern ...

Achieved 100% ORR and 83.3% CR rate at dose level 2 following a single infusion in patients with relapsed/refractory B-NHL in an ongoing Phase 1 study No dose-limiting toxicities, serious adverse ...

Sorsby's proposed punishment of a two-game suspension for gambling on college football, instead of permanent ineligibility per NCAA rules, was accepted by a district court judge. Ron Jenkins / Getty ...

The Big 12 Conference filed a complaint in federal court seeking a declaratory judgment that would allow the league to enforce its bylaws and potentially sanction member Texas Tech should the school ...

Texas Attorney General Ken Paxton (R), a candidate for Senate, is warning schools across the Big 12 Conference that the state would consider suing any institution that sanctions Texas Tech over a ...

No dose-limiting toxicities, serious adverse events, ICANS, or deaths were reported; infusion-related reactions and CRS were Grade 1–2, and none required glucocorticoids for CRS management Additional ...

Good news? Texas Tech quarterback Brendan Sorsby has regained his eligibility to play college football in 2026. Bad news? The Red Raiders could have no one to play against. Via Ross Dellenger of Yahoo ...